Low-frequency Transcranial Magnetic Stimulation To Enhance Motor Recovery In The Subacute Phase After Stroke
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Low-frequency repetitive transcranial magnetic stimulation (rTMS) of the unaffected hemisphere (UH) transiently improves motor function in patients in the chronic phase after stroke. The goal of this study is to investigate effects on motor recovery of low-frequency rTMS of the UH, administered in the subacute phase after stroke.
| Condition | Intervention | Phase |
|---|---|---|
|
Stroke |
Other: Repetitive transcranial magnetic stimulation |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Low-frequency Transcranial Magnetic Stimulation To Enhance Motor Recovery In The Subacute Phase After Stroke |
- Motor function of the paretic hand evaluated with the Jebsen-Taylor test [ Time Frame: Baseline, two weeks, 1 month, 3 and six months after end of treatment ] [ Designated as safety issue: No ]
- Number of Participants with Adverse Events as a Measure of Safety and Tolerability [ Time Frame: Baseline, two weeks, 1 month, 3 and six months after end of treatment ] [ Designated as safety issue: Yes ]
- Number of patients able to comply with the protocol [ Time Frame: Baseline, two weeks, 1 month, 3 and six months after end of treatment ] [ Designated as safety issue: No ]
- Force of the paretic hand [ Time Frame: Baseline, two weeks, 1 month, 3 and six months after end of treatment ] [ Designated as safety issue: No ]
- Fugl-Meyer evaluation of motor performance (upper limb) [ Time Frame: Baseline, two weeks, 1 month, 3 and six months after end of treatment ] [ Designated as safety issue: No ]
- Disability evaluated with the modified Rankin scale [ Time Frame: Baseline, two weeks, 1 month, 3 and six months after end of treatment ] [ Designated as safety issue: No ]
- Functional Independence Measure [ Time Frame: Baseline, two weeks, 1 month, 3 and six months after end of treatment ] [ Designated as safety issue: No ]
- Neurological impairment evaluated with the NIH Stroke Scale [ Time Frame: Baseline, two weeks, 1 month, 3 and six months after end of treatment ] [ Designated as safety issue: No ]
- Measures of corticomotor excitability evaluated with transcranial magnetic stimulation [ Time Frame: Baseline, two weeks, 1 month, 3 and six months after end of treatment ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 36 |
| Study Start Date: | February 2008 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | July 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Active rTMS
1Hz active rTMS delivered to the unaffected hemisphere
|
Other: Repetitive transcranial magnetic stimulation
Repetitive transcranial magnetic stimulation, frequency of 1Hz, once a day for ten days.
|
|
Placebo Comparator: Placebo rTMS
1Hz placebo rTMS delivered to the vertex
|
Other: Repetitive transcranial magnetic stimulation
Repetitive transcranial magnetic stimulation, frequency of 1Hz, once a day for ten days.
|
Detailed Description:
Stroke is a major cause of disability and worldwide. Hand motor impairment is frequent after stroke. Even mild impairments of the upper limb negatively impact disability and quality of life in these patients significantly contributes to disability. Therapeutic alternatives for hand motor rehabilitation are deeply needed.
Repetitive transcranial magnetic stimulation (rTMS) has emerged as a potential tool to improve hand motor performance after stroke. While high-frequency rTMS (HF-rTMS) often increases motor cortical excitability, LF-rTMS often has the opposite effect. Up-regulation of excitability in the affected hemisphere by HF-rTMS or down-regulation of the UH by LF-rTMS can restore the balance in inter-hemispheric inhibition and hence, facilitate movement of the paretic hand Both strategies, as well as the combination of both, have yielded encouraging results when applied in proof-of-principle, single-session studies to patients with mild hand motor impairment in the subacute and chronic stages after stroke. However, few rTMS studies included patients less than six months after stroke, and effects of LF-rTMS of the unaffected hemisphere in patients with severe motor impairment in the subacute phase have not been yet reported.
The investigators opted for a novel approach to enhance hand motor recovery, by examining feasibility, safety and preliminary efficacy of either active or sham LF-rTMS of the UH or sham rTMS as add-on therapies to outpatient customary rehabilitation, to patients with mild to severe hand paresis, within 5-45 days after unilateral ischemic stroke. The investigators hypothesize that, at this stage, LF-rTMS will be feasible even in patients with severe motor deficits, will have minimal adverse events and will enhance effects of customary rehabilitation on hand motor performance.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- First-ever ischemic stroke in the internal carotid artery territory confirmed by CT or MRI, 5-45 days before, leading to contralateral hand weakness
- Age, 18-80 years
Exclusion Criteria:
- Cardiac pacemaker
- Pregnancy
- Implantable medication pump
- Intracranial hypertension
- History of seizures
- Metal in the head
- Decompressive surgery
- Other neurological diseases
- Shoulder pain
- Joint deformity in the paretic upper limb
- Severe chronic disease such as end-stage cancer or end-stage renal failure
- Inability to provide informed consent due to severe language or cognitive impairment
Contacts and Locations| Contact: Adriana Conforto, MD, PhD | adriana.conforto@gmail.com |
| Brazil | |
| Laboratório de Neuroestimulação, HC/FMUSP | Recruiting |
| São Paulo, SP, Brazil, 05403000 | |
| Contact: Adriana Conforto, MD, PhD adriana.conforto@gmail.com | |
| Principal Investigator: | Adriana Conforto, MD, PhD | HC/FMUSP/Fundação Faculdade de Medicina |
More Information
No publications provided
| Responsible Party: | Adriana B. Conforto/ Chief, Neurostimulation Laboratory, Divisão de Clínica Neurológica, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo |
| ClinicalTrials.gov Identifier: | NCT01333579 History of Changes |
| Other Study ID Numbers: | NCT2006/55504-0 |
| Study First Received: | April 4, 2011 |
| Last Updated: | April 11, 2011 |
| Health Authority: | Brazil: Ethics Committee |
Additional relevant MeSH terms:
|
Stroke Cerebral Infarction Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases Brain Infarction Brain Ischemia |
ClinicalTrials.gov processed this record on June 17, 2013